Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06395103
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-02-01
Brief Title:
Substudy 01A Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors MK-9999-01ALIGHTBEAM-U01
Sponsor:
Organization:
Merck Sharp Dohme LLC